Our collaboration with MediSage to present 'Current Approaches to Uro-Oncology' embodies a crucial stride towards comprehensive cancer care
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
The cognitively operated system is a mother patent invention, first launched in India
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Subscribe To Our Newsletter & Stay Updated
